Patents by Inventor CHRISTINA KIZIRIDI

CHRISTINA KIZIRIDI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUSTAINED RELEASE COMPOSITION COMPRISING TAPENTADOL OXALATE AND METHOD OF PREPARATION THEREOF
    Publication number: 20220202720
    Abstract: The present invention relates to a sustained release composition comprising Tapentadol or a pharmaceutically acceptable salt thereof for oral administration for the treatment of severe chronic pain in adults.
    Type: Application
    Filed: March 20, 2020
    Publication date: June 30, 2022
    Applicant: PHARMATHEN S.A.
    Inventors: Evangelos KARAVAS, Efthymios KOUTRIS, Vasiliki SAMARA, Ioanna KOUTRI, Anastasia KALASKANI, Christina KIZIRIDI, Andreas KAKOURIS
  • PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF
    Publication number: 20210169807
    Abstract: The present invention relates to controlled release pharmaceutical formulations comprising an atypical antipsychotic agent such as Paliperidone or pharmaceutical acceptable salt thereof in the form of a multi-layer tablet that provides zero order drug release. It also relates to a process for the preparation thereof.
    Type: Application
    Filed: November 30, 2020
    Publication date: June 10, 2021
    Applicant: PHARMATHEN S.A.
    Inventors: EVANGELOS KARAVAS, EFTHYMIOS KOUTRIS, VASILIKI SAMARA, IOANNA KOUTRI, ANASTASIA KALASKANI, LIDA KALANTZI, MORFIS ABATZIS, CHRISTINA KIZIRIDI
  • PHARMACEUTICAL COMPOSITION COMPRISING A NON-PURINE SELECTIVE INHIBITOR OF XANTHINE OXIDASE AND METHOD FOR THE PREPARATION THEREOF
    Publication number: 20190151293
    Abstract: The present invention relates to a stable pharmaceutical formulation of solid dosage forms for oral administration comprising a therapeutically effective amount of a non-purine selective inhibitor of xanthine oxidase, in particular Febuxostat and an effective amount of an alkalizing agent. It also relates to a process for the preparation thereof.
    Type: Application
    Filed: June 26, 2017
    Publication date: May 23, 2019
    Applicant: PHARMATHEN S.A.
    Inventors: EVANGELOS KARAVAS, EFTHYMIOS KOUTRIS, VASILIKI SAMARA, IOANNA KOUTRI, ANASTASIA KALASKANI, CHRISTINA KIZIRIDI, MORFIS ABATZIS, KATERINA TSILIOUKA
  • PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF
    Publication number: 20190105277
    Abstract: The present invention relates to controlled release pharmaceutical formulations comprising an atypical antipsychotic agent such as Paliperidone in the form of capsule filled with mini-tablets that provide zero order drug release. It also relates to a process for the preparation thereof.
    Type: Application
    Filed: April 5, 2016
    Publication date: April 11, 2019
    Applicant: PHARMATHEN S.A.
    Inventors: Evangelos KARAVAS, Efthimios KOUTRIS, Vasiliki SAMARA, Ioanna KOUTRI, Lida KALANTZI, Anastasia KALASKANI, Christina KIZIRIDI, Morfis ABATZIS
  • PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF
    Publication number: 20180214381
    Abstract: The present invention relates to controlled release pharmaceutical formulations comprising an atypical antipsychotic agent such as Paliperidone or pharmaceutical acceptable salt thereof in the form of a multi-layer tablet that provides zero order drug release. It also relates to a process for the preparation thereof.
    Type: Application
    Filed: July 7, 2016
    Publication date: August 2, 2018
    Applicant: PHARMATHEN S.A.
    Inventors: EVANGELOS KARAVAS, EFTHYMIOS KOUTRIS, VASILIKI SAMARA, IOANNA KOUTRI, ANASTASIA KALASKANI, LIDA KALANTZI, MORFIS ABATZIS, CHRISTINA KIZIRIDI